Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 26, 2016Annals of the Rheumatic DiseasesOpen Access

Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques

View Full Paper
Ask AI
Bookmark
Share

Authors

PCPhilip G. ConaghanMØMikkel ØstergaardMBM.A. Bowes

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Conaghan et al. (2016) studied this question.

synapsesocial.com/papers/6a761ae49aebbbed3661420fhttps://doi.org/10.1136/annrheumdis-2015-208267
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dynamic gadolinium-enhanced magnetic resonance imaging allows accurate assessment of the synovial inflammatory activity in rheumatoid arthritis knee joints: a comparison with synovial histology2012 · 67 citations
  2. 2The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double‐blind, placebo‐controlled phase IIa trial of three dosage levels of CP‐690,550 versus placebo2009 · 546 citations
  3. 3Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study2013 · 586 citations
  4. 4Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis2012 · 1,043 citations